Broad view

This guide summarizes chloroquine use on Australian soil. It covers common evidence, practical administration notes, normal dosing patterns, observation and tracking needs for longer therapy, approximate Australian dollar prices, and how people commonly obtain this medication withon Australian soil. Jump straight to the dosing and schedules or access that is legal sections for easy reference.

In a quick view:

  • Active substance in the product: chloroquine, usually supplied as chloroquine phosphate; many dosing references convert values to chloroquine base.
  • Main purposes: antimalarial agent and treatment of some invasive amebic infections.
  • Usual tablet strengths encountered: 250 mg and 500 mg chloroquine phosphate. A 500 mg phosphate tablet roughly equals 300 mg chloroquine base for dosing comparisons.
  • Brand and supply: Aralen is a known brand internationally; in Australia generic preparations or clinic stocks are most common.

Clinical applications

Chloroquine remains useful in settings where the parasite remains sensitive. Typical symptoms include:

  • Treatment and weekly suppression of malaria caused by Plasmodium vivax, P. malariae, P. ovale, and susceptible strains of P. falciparum.
  • Management of extraintestinal amebiasis in combination with a luminal amebicide when indicated.

Important message: chloroquine resistance in P. falciparum is widespread in many regions. For travel to such areas, clinicians often choose a side option antimalarials. See option choices and value based pricing for commonly used substitutes.

What is the proper way to take chloroquine

Follow the exact instructions from your prescriber. The following points can help reduce minor detrimental outcomes and improve adherence:

  • Take with food or a glass of milk if you get stomach upset, unless your clinician tells you otherwise.
  • Do not alter the dose or dosing frequency without medical advice.
  • If using weekly prophylaxis, pick one day each week and try to take the tablet on that same weekday to form a habit.
  • Finish the entire prescribed course, even if symptoms improve, to reduce risk of relapse or treatment failure.
  • When a dose has been missed, take it as soon as you remember unless the next dose is due soon. Avoid taking two doses at once to catch up.

Pediatric regimens must be individually calculated by weight and prescribed by a clinician. See dosage and schedules for example regimens used for adults and children.

Dose administration schedule

Many references quote doses as chloroquine base. Use the prescriber's directions first and foremost. For orientation, 500 mg chloroquine phosphate corresponds to about 300 mg chloroquine base. Weight-based dosing is essential for children.

Preventive malaria therapy - weekly suppression

  • Adults: 500 mg chloroquine phosphate (approximately 300 mg base) once weekly on a consistent day.
  • Boys and girls: around 5 mg/kg base weekly, adjusted to not exceed the adult dosage.
  • Start taking prophylaxis 1 to 2 weeks before entering an area where chloroquine-sensitive malaria occurs. If starting late, an adult loading regimen may be used (for example, 1 g phosphate split into two doses 6 hours apart); children receive a weight-proportional loading dose.
  • Continue weekly dosing while in the area and for 8 weeks after departure.

Acute malaria care and treatment

  • Adults: typical course is an initial 1 g chloroquine phosphate (about 600 mg base), followed by 500 mg (about 300 mg base) after 6 to 8 hours, then 500 mg daily on days 2 and 3. Total roughly 2.5 g phosphate over three days.
  • Minor children: dosing is weight-based. An example schedule uses an initial 10 mg/kg base (not usually exceeding the adult single-dose maximum), then 5 mg/kg after 6 hours, and further 5 mg/kg doses at 24 and 36 hours from the first dose.
  • For radical cure of relapsing species such as P. vivax or plasmodium. ovale, an additional 8-aminoquinoline (for example primaquine) is generally required where safe to use.

Extraintestinal Entamoeba histolytica infection

  • Adults: a common approach is 1 g chloroquine phosphate (about 600 mg base) daily for two days, then 500 mg (about 300 mg base) daily for 2 to 3 weeks, usually combined with a luminal agent to clear intestinal carriage.

If you have questions about dosing during pregnancy, for infants, or for people with coexisting medical conditions, consult a specialist. See safety and continuous monitoring integration for recommended follow up when therapy is prolonged.

Archival the term storage describes a place or method for preserving goods or information.

  • Keep in a tightly closed container at normal room temperature and avoid direct sunlight.
  • Protect from excessive heat and moisture. Do not refrigerate or freeze tablets unless the manufacturer specifies otherwise.
  • Store all medicines out of reach of children and pets.
  • Return expired or unwanted medicines to a pharmacy or use local medicine take-back services for safe disposal.

Occupational safety and continuous monitoring processes

Although short courses and prophylactic regimens are generally well tolerated, chloroquine can cause adverse health effects that may require keeping track of metrics when treatment is extended.

  • Eye care: report blurred vision, new visual disturbances, or reduced visual acuity promptly. Long-term therapy may require periodic ophthalmology review.
  • Blood and muscle surveillance: prolonged use can warrant blood tests and assessment for muscle symptoms or blood dyscrasias.
  • Driving and tasks: do not drive or operate heavy machinery if vision or concentration is affected.
  • Drug interaction alerts: inform your prescriber about all prescription medicines, over-the-counter products, and supplements to avoid personal interactions build trust and rapport..
  • Pregnancy through lactation: decisions should be individualized with an obstetrician or infectious diseases clinician weighing benefits and risks.

Secondary effects and advisories

The risk of adverse reactions increases with higher doses and longer duration of treatment. Seek medical attention for severe or concerning symptoms.

Go to the hospital immediately for signs of infection

  • Sudden vision loss, severe eye pain, or a major change in sight.
  • Black or tarry stools, blood in urine or stools, unusual bleeding or easy bruising.
  • Seizure spells, marked mood or behavior changes, new hearing loss or persistent ringing in the ears.
  • High fever with sore throat or other signs of infection, fainting, or severe lightheadedness.
  • New or worsening muscle weakness, severe abdominal or flank pain, or painful urination.

Excess dose of a drug danger signals

  • Severe drowsiness, extreme head pains, agitation, confusion or collapse. ODing is a medical emergency and requires immediate hospital care.

Ordinary possible side effects or mild effects

  • Nausea accompanied by vomiting
  • Itching, which may be more noticeable in some populations
  • Cranial ache
  • Diarrhea
  • Appetite is suppressed or abdominal cramping
  • Difficulty with focusing or reading due to transient visual blurring

Less frequent reaction types

  • Changes in hair color or increased hair loss
  • Blue-black discoloration of skin, nails, or mucous membranes
  • Rashes and other skin reactions

Some adverse effects may continue or evolve after stopping the medicine. If you notice new or worsening symptoms after finishing therapy, get medical review without delay.

AUD price options

Treatment choice depends on travel destination, parasite species and resistance patterns, patient medical history, and tolerability. The price bands below are approximate Australian retail costs and will vary by brand, pack size, pharmacy, and PBS subsidy status.

Common malaria different avenues

  • Atovaquone/proguanil 250/100 mg: commonly chosen where chloroquine resistance occurs. Typical travel packs retail for around AUD 60 to 120.
  • Doxycycline 100 mg: an effective prophylactic option; retail cost often between AUD 10 and 25 depending on quantity.
  • Mefloquine 250 mg: weekly prophylaxis an alternate approach; packs commonly retail for AUD 40 to 90.
  • Artemisinin-based combination therapy (for treatment): artemether/lumefantrine is an example treatment course costing roughly AUD 40 to 100.
  • Hydroxychloroquine 200 mg: a related drug with different licensed uses and a different safety profile; private purchase prices vary, typically around AUD 60 to 100 for common pack sizes, while PBS subsidy can lower patient costs for approved suggestions.
  • Chloroquine phosphate 500 mg: limited use in many areas due to resistance; if available privately retail may be roughly AUD 20 to 50 for small packs.

Amebiasis: an alternate possibility approaches

  • Metronidazole: the usual tissue-active agent for invasive amebiasis; often followed by a luminal agent. Approximate cost AUD 10 to 20 for a standard course.
  • Tinidazole: similar activity with some shorter regimens. Typical retail prices are about AUD 8 to 15 for a short supply.
  • Paromomycin (luminal agent): availability can be limited and may require special ordering; prices range widely, often AUD 80 to 200 or more.
  • Iodoquinol and diloxanide furoate: other luminal options with variable availability and cost when specially sourced.

Discuss options with a travel medicine clinic or infectious diseases specialist to choose the safest, most effective regimen for your itinerary and health status. Where medicines are listed on the PBS, patient copayments are lower; check the current PBS listings for up-to-date subsidy and eligibility this information. For quick comparisons see malaria various options and amebiasis other possibilities.

Additional aspects about Chloroquine